Novel Approaches for Overcoming Biological Barriers
| dc.contributor.editor | Agrahari, Vibhuti | |
| dc.contributor.editor | Kumar, Prashant | |
| dc.date.accessioned | 2023-06-23T09:51:52Z | |
| dc.date.available | 2023-06-23T09:51:52Z | |
| dc.date.issued | 2023 | |
| dc.identifier | ONIX_20230623_9783036576992_131 | |
| dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/100899 | |
| dc.description.abstract | The human body poses various biological barriers to protect itself from pathogens, foreign materials and is important for its functioning and development. This reprint serves as a collection of research and review articles describing novel approaches and new therapeutic modalities to overcome biological barriers. This collection is a must read for scientists working in the field of drug and vaccine delivery. | |
| dc.language | English | |
| dc.subject.classification | thema EDItEUR::M Medicine and Nursing | en_US |
| dc.subject.classification | thema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries | en_US |
| dc.subject.other | blood-brain barrier | |
| dc.subject.other | integrity marker | |
| dc.subject.other | sorbitol | |
| dc.subject.other | positron emission tomography | |
| dc.subject.other | focused ultrasound | |
| dc.subject.other | zolmitriptan | |
| dc.subject.other | intranasal | |
| dc.subject.other | bilosomes | |
| dc.subject.other | sodium deoxycholate | |
| dc.subject.other | mucoadhesive gel | |
| dc.subject.other | brain targeting | |
| dc.subject.other | blood–brain barrier | |
| dc.subject.other | drug formulation | |
| dc.subject.other | drug hybrids | |
| dc.subject.other | intra-arterial delivery | |
| dc.subject.other | intracranial malignancies | |
| dc.subject.other | intranasal delivery | |
| dc.subject.other | monoterpene | |
| dc.subject.other | monoterpenoid | |
| dc.subject.other | NEO100 | |
| dc.subject.other | carbomer hydrogel | |
| dc.subject.other | whitening agents | |
| dc.subject.other | enhancers | |
| dc.subject.other | enhancement site and mechanism | |
| dc.subject.other | drug release and permeation | |
| dc.subject.other | inhaled drug delivery | |
| dc.subject.other | prodrug | |
| dc.subject.other | liposome formulation | |
| dc.subject.other | propofol | |
| dc.subject.other | micelle | |
| dc.subject.other | DSPE mPEG2k | |
| dc.subject.other | Solutol HS 15 | |
| dc.subject.other | diclofenac | |
| dc.subject.other | optimization | |
| dc.subject.other | pharmacokinetic | |
| dc.subject.other | pharmacodynamic study | |
| dc.subject.other | long acting | |
| dc.subject.other | sustained delivery | |
| dc.subject.other | biologics | |
| dc.subject.other | silica microparticles | |
| dc.subject.other | exosome | |
| dc.subject.other | brain delivery | |
| dc.subject.other | BBB crossing | |
| dc.subject.other | transcytosis | |
| dc.subject.other | peptide-drug conjugates | |
| dc.subject.other | blood–placental barrier | |
| dc.subject.other | Zika virus | |
| dc.subject.other | BBB shuttles | |
| dc.subject.other | porphyrins | |
| dc.subject.other | antivirals | |
| dc.subject.other | epidermal growth factor receptor | |
| dc.subject.other | non-small cell lung cancer | |
| dc.subject.other | Lamin B2 | |
| dc.subject.other | AMPK | |
| dc.subject.other | Osimertinib | |
| dc.subject.other | RNA seq | |
| dc.subject.other | proteomics | |
| dc.subject.other | RT-PCR | |
| dc.subject.other | blood–brain tumor barrier | |
| dc.subject.other | permeabilization | |
| dc.subject.other | brain tumors | |
| dc.subject.other | primary central nervous system lymphoma | |
| dc.subject.other | tumor necrosis factor-alpha | |
| dc.subject.other | targeted delivery | |
| dc.subject.other | vascular targeting | |
| dc.subject.other | CD13 | |
| dc.subject.other | TNF | |
| dc.subject.other | TNF receptors | |
| dc.subject.other | NGR-TNF | |
| dc.subject.other | polyamidoamine dendrimers | |
| dc.subject.other | diabetic retinopathy | |
| dc.subject.other | protein kinase C-β inhibitor | |
| dc.subject.other | nanoparticles | |
| dc.subject.other | ruboxistaurin | |
| dc.subject.other | blood brain barrier | |
| dc.subject.other | electropermanent magnet | |
| dc.subject.other | magnetic resonance imaging | |
| dc.subject.other | n/a | |
| dc.title | Novel Approaches for Overcoming Biological Barriers | |
| dc.type | book | |
| oapen.identifier.doi | 10.3390/books978-3-0365-7698-5 | |
| oapen.relation.isPublishedBy | 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 | |
| oapen.relation.isbn | 9783036576992 | |
| oapen.relation.isbn | 9783036576985 | |
| oapen.pages | 270 | |
| oapen.place.publication | Basel |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||

